ACTIVE IMMUNIZATION OF HIV-1 INFECTED, PREGNANT WOMEN WITH CD4 LYMPHOCYTE COUNTS >= 400/MM3: A PHASE I STUDY OF SAFETY AND IMMUNOGENICITY OF MN RGP120/HIV-1 VACCINE (NOTE: SOME PATIENTS RECEIVE PLACEBO):